X 
Board Meetings
Home | Market Info | Company Profile | Board Meetings
Glaxosmithkline Consumer Healthcare Ltd. - (Amalgamated)
BSE CODE: 500676   |   NSE CODE: NA   |   ISIN CODE : INE264A01014   |   15-Apr-2020 Hrs IST
BSE NSE
Rs. 10753.65
0 ( 0% )
 
Prev Close ( Rs.)
10753.65
Open ( Rs.)
10500.00
 
High ( Rs.)
10845.75
Low ( Rs.)
10394.05
 
Volume
2533
Week Avg.Volume
1213
 
52 WK High-Low Range(Rs.)
BSE NSE
Rs.
( )
 
Prev Close ( Rs.)
Open ( Rs.)
 
High ( Rs.)
Low ( Rs.)
 
Volume
Week Avg.Volume
92964
 
52 WK High-Low Range(Rs.)
Source DateBoard Meeting DateDetails
13-Jan-2020 06-Feb-2020 Quarterly Results
14-Oct-2019 07-Nov-2019 GLAXOSMITHKLINE CONSUMER HEALTHCARE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2019 ,inter alia, to consider and approve Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015, Notice is hereby given that a meeting of the Board of Directors will be held on Thursday, November 07, 2019 at the Corporate Office of the Company situated at 24th & 25th Floor, One Horizon Center, DLF Phase - V, Golf Course Road, Gurugram 122002 to, inter alia, to consider and take on record the Unaudited Financial Results for the Second Quarter ended September 30, 2019 with Limited Review by Auditors. We request you to take the above information on record.
27-Jun-2019 01-Aug-2019 Quarterly Results
03-May-2019 10-May-2019 Final Dividend & A.G.M. & Audited Results
07-Feb-2019 14-Feb-2019 Quarterly Results
22-Oct-2018 01-Nov-2018 Quarterly Results
23-Jul-2018 07-Aug-2018 Quarterly Results
03-May-2018 11-May-2018 Audited Results & Dividend
20-Mar-2018 28-Mar-2018 Please note that a meeting of the Board of Directors of the Company will be held on Wednesday, March 28, 2018 at 9.00 a.m. at the Corporate Office of the Company situated at 24th & 25th Floor, One Horizon Centre, DLF Phase - V, Golf Course Road, Gurugram 122002 to discuss future strategies of the Company. The above may be taken as our intimation under Regulation 29 of SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015.
05-Feb-2018 12-Feb-2018 Quarterly Results
Page 1 of 8
PREV || NEXT